J M Trzaskos - JoVE Visualize

Showing results (41-50 of 56) with videos related to

Pageof 6

Sort By:

Biochemistry|August 1, 1995

Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition propertiesJ M Trzaskos, S S Ko, R L Magolda, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998

Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytesP A Scherle, E A Jones, M F Favata, et al.

Annals of the New York Academy of Sciences|July 23, 1999

Aggrecanase. A target for the design of inhibitors of cartilage degradationE C Arner, M A Pratta, C P Decicco, et al.

Biochemical and Biophysical Research Communications|February 19, 2000

Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivoB D Jaffee, E J Manos, R J Collins, et al.

Genes & Development|July 1, 1999

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdeltaH Lim, R A Gupta, W G Ma, et al.

The Journal of Biological Chemistry|October 25, 1993

Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesisJ M Trzaskos, R L Magolda, M F Favata, et al.

Journal of Enzyme Inhibition|January 1, 1996

Comparative effects of selective cyclooxygenase 1 and cyclooxygenase 2 inhibitors on myeloperoxidase and 3 alpha-hydroxysteroid dehydrogenaseN L Rider, D Pinto, M Covington, et al.

Molecular and Cellular Biology|October 19, 1999

Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activationI P Whitehead, Q T Lambert, J A Glaven, et al.

Bioorganic & Medicinal Chemistry Letters|May 7, 1999

Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogsD J Pinto, D G Batt, W J Pitts, et al.

Journal of Medicinal Chemistry|October 5, 2001

Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.

Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:

Pageof 6

Biochemistry|August 1, 1995

Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition propertiesJ M Trzaskos, S S Ko, R L Magolda, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998

Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytesP A Scherle, E A Jones, M F Favata, et al.

Annals of the New York Academy of Sciences|July 23, 1999

Aggrecanase. A target for the design of inhibitors of cartilage degradationE C Arner, M A Pratta, C P Decicco, et al.

Biochemical and Biophysical Research Communications|February 19, 2000

Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivoB D Jaffee, E J Manos, R J Collins, et al.

Genes & Development|July 1, 1999

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdeltaH Lim, R A Gupta, W G Ma, et al.

The Journal of Biological Chemistry|October 25, 1993

Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesisJ M Trzaskos, R L Magolda, M F Favata, et al.

Journal of Enzyme Inhibition|January 1, 1996

Comparative effects of selective cyclooxygenase 1 and cyclooxygenase 2 inhibitors on myeloperoxidase and 3 alpha-hydroxysteroid dehydrogenaseN L Rider, D Pinto, M Covington, et al.

Molecular and Cellular Biology|October 19, 1999

Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activationI P Whitehead, Q T Lambert, J A Glaven, et al.

Bioorganic & Medicinal Chemistry Letters|May 7, 1999

Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogsD J Pinto, D G Batt, W J Pitts, et al.

Journal of Medicinal Chemistry|October 5, 2001

Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.

Pageof 6